The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation
The diverse modes of action of small molecule inhibitors provide versatile tools to investigate basic biology and develop therapeutics. However, it remains a challenging task to evaluate their exact mechanisms of action. We identified two classes of inhibitors for the p97 ATPase: ATP competitive and...
Main Authors: | Feng Wang, Shan Li, Kai-Wen Cheng, William M. Rosencrans, Tsui-Fen Chou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/2/204 |
Similar Items
-
Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication
by: Kai-Wen Cheng, et al.
Published: (2021-10-01) -
Endo-Lysosomal and Autophagy Pathway and Ubiquitin-Proteasome System in Mood Disorders: A Review Article
by: Matutino Santos P, et al.
Published: (2023-01-01) -
Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease
by: Drew A. Gillett, et al.
Published: (2023-11-01) -
Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes
by: Eli Olson, et al.
Published: (2023-02-01) -
NMS-873 Leads to Dysfunctional Glycometabolism in A p97-Independent Manner in HCT116 Colon Cancer Cells
by: Shan Li, et al.
Published: (2022-03-01)